Published in J Virol on August 01, 1993
Picornavirus nonstructural proteins: emerging roles in virus replication and inhibition of host cell functions. J Virol (1993) 1.72
Nucleocytoplasmic traffic disorder induced by cardioviruses. J Virol (2006) 1.59
Tumor-specific proteolytic processing of cyclin E generates hyperactive lower-molecular-weight forms. Mol Cell Biol (2001) 1.58
Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores. J Virol (2004) 1.43
Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity. J Virol (2010) 1.40
Specific cleavage of the nuclear pore complex protein Nup62 by a viral protease. J Biol Chem (2010) 1.13
Targeted overexpression of elafin protects mice against cardiac dysfunction and mortality following viral myocarditis. J Clin Invest (1999) 1.05
The dietary phytochemical indole-3-carbinol is a natural elastase enzymatic inhibitor that disrupts cyclin E protein processing. Proc Natl Acad Sci U S A (2008) 1.00
A stable HeLa cell line that inducibly expresses poliovirus 2A(pro): effects on cellular and viral gene expression. J Virol (2000) 0.98
Calpain 1 and 2 are required for RNA replication of echovirus 1. J Virol (2007) 0.96
Oxysterol-binding protein family I is the target of minor enviroxime-like compounds. J Virol (2013) 0.93
A novel mechanism of eukaryotic translation initiation that is neither m7G-cap-, nor IRES-dependent. Nucleic Acids Res (2012) 0.88
Dual inhibition of human rhinovirus 2A and 3C proteases by homophthalimides. Antimicrob Agents Chemother (1998) 0.87
Genetic selection of poliovirus 2Apro-binding peptides. J Virol (1999) 0.87
Translation without eIF2 promoted by poliovirus 2A protease. PLoS One (2011) 0.85
Enzymatic characterization of refolded human rhinovirus type 14 2A protease expressed in Escherichia coli. J Virol (1998) 0.82
Ex vivo and in vivo inhibition of human rhinovirus replication by a new pseudosubstrate of viral 2A protease. J Virol (2011) 0.78
Selective Removal of FG Repeat Domains from the Nuclear Pore Complex by Enterovirus 2Apro. J Virol (2015) 0.77
Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (1981) 16.61
A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol (1988) 13.93
Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 8.59
Viral proteinases. Annu Rev Biochem (1988) 6.76
A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell (1986) 5.53
Proteolytic processing of poliovirus polypeptides: antibodies to polypeptide P3-7c inhibit cleavage at glutamine-glycine pairs. Proc Natl Acad Sci U S A (1982) 5.50
Cell-free, de novo synthesis of poliovirus. Science (1991) 5.09
Poliovirus mutant that does not selectively inhibit host cell protein synthesis. Mol Cell Biol (1985) 4.94
Improved method for staining cell monolayers for virus plaque counts. J Bacteriol (1959) 4.94
Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J Virol (1987) 4.52
Viral cysteine proteases are homologous to the trypsin-like family of serine proteases: structural and functional implications. Proc Natl Acad Sci U S A (1988) 4.32
Mapping the active site of papain with the aid of peptide substrates and inhibitors. Philos Trans R Soc Lond B Biol Sci (1970) 3.29
Poliovirus polypeptide precursors: expression in vitro and processing by exogenous 3C and 2A proteinases. Proc Natl Acad Sci U S A (1987) 2.98
Translation of poliovirus RNA: role of an essential cis-acting oligopyrimidine element within the 5' nontranslated region and involvement of a cellular 57-kilodalton protein. J Virol (1991) 2.86
Translational enhancement of the poliovirus 5' noncoding region mediated by virus-encoded polypeptide 2A. Proc Natl Acad Sci U S A (1992) 2.65
Cap-independent translation of picornavirus RNAs: structure and function of the internal ribosomal entry site. Enzyme (1990) 2.51
Role of maturation cleavage in infectivity of picornaviruses: activation of an infectosome. J Virol (1993) 2.39
Structure, function and evolution of picornaviruses. J Gen Virol (1990) 2.17
Carboxy-terminal analysis of poliovirus proteins: termination of poliovirus RNA translation and location of unique poliovirus polyprotein cleavage sites. J Virol (1982) 2.11
Cardioviral internal ribosomal entry site is functional in a genetically engineered dicistronic poliovirus. Nature (1992) 2.10
A collaborative report: rhinoviruses--extension of the numbering system from 89 to 100. Virology (1987) 2.10
Proteolytic processing of polyproteins in the replication of RNA viruses. Biochemistry (1989) 2.04
Specificity of porcine pancreatic elastase, human leukocyte elastase and cathepsin G. Inhibition with peptide chloromethyl ketones. Biochim Biophys Acta (1977) 1.84
Human rhinovirus 14 infection of HeLa cells results in the proteolytic cleavage of the p220 cap-binding complex subunit and inactivates globin mRNA translation in vitro. J Virol (1985) 1.79
Inhibition of translation in cells infected with a poliovirus 2Apro mutant correlates with phosphorylation of the alpha subunit of eucaryotic initiation factor 2. J Virol (1989) 1.77
Human leukocyte and porcine pancreatic elastase: X-ray crystal structures, mechanism, substrate specificity, and mechanism-based inhibitors. Biochemistry (1989) 1.68
Identification of essential amino acid residues in the functional activity of poliovirus 2A protease. Virology (1991) 1.61
Eukaryotic initiation factor 3 is required for poliovirus 2A protease-induced cleavage of the p220 component of eukaryotic initiation factor 4F. Proc Natl Acad Sci U S A (1990) 1.58
Proteolytic processing of poliovirus polyprotein: elimination of 2Apro-mediated, alternative cleavage of polypeptide 3CD by in vitro mutagenesis. Virology (1988) 1.43
Determinants of substrate recognition by poliovirus 2A proteinase. J Virol (1992) 1.29
Polypeptide 2A of human rhinovirus type 2: identification as a protease and characterization by mutational analysis. Virology (1989) 1.26
Antigenic conservation and divergence between the viral-specific proteins of poliovirus type 1 and various picornaviruses. Virology (1985) 1.20
Active-site specific inhibitors of elastase. Biochemistry (1973) 1.19
Use of peptide aldehydes to generate transition-state analogs of elastase. Biochemistry (1973) 1.18
Aldehydes as inhibitors of papain. J Biol Chem (1972) 1.17
Purification and partial characterization of poliovirus protease 2A by means of a functional assay. J Virol (1988) 1.13
Peptide chloromethyl ketones as irreversible inhibitors of elastase. Biochemistry (1973) 1.12
Substrate requirements of a human rhinoviral 2A proteinase. Virology (1991) 1.06
Dependence of the kinetic parameters for elastase-catalyzed amide hydrolysis on the length of peptide substrates. Biochemistry (1973) 1.01
Inhibition of human leukocyte elastase (HLE) by N-substituted peptidyl trifluoromethyl ketones. J Med Chem (1992) 0.94
Synthetic elastase inhibitors: prospects for use in the treatment of emphysema. Am Rev Respir Dis (1983) 0.89
Inhibitors of leukocyte elastase and leukocyte cathepsin G. Agents for the treatment of emphysema and related ailments. Med Res Rev (1987) 0.86
Active site of alpha-lytic protease: enzyme-substrate interactions. Eur J Biochem (1981) 0.85
Catalysis by human leukocyte elastase: mechanistic insights into specificity requirements. Biochemistry (1987) 0.81
Cleavage site between VP1 and P2A of human rhinovirus is different in serotypes 2 and 14. J Gen Virol (1987) 0.80
Viral proteases as targets for chemotherapeutic intervention. Curr Opin Biotechnol (1992) 0.77
Primary structure, gene organization and polypeptide expression of poliovirus RNA. Nature (1981) 16.61
A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol (1988) 13.93
Cellular receptor for poliovirus: molecular cloning, nucleotide sequence, and expression of a new member of the immunoglobulin superfamily. Cell (1989) 9.82
Synthesis of infectious poliovirus RNA by purified T7 RNA polymerase. Proc Natl Acad Sci U S A (1986) 8.59
A protein covalently linked to poliovirus genome RNA. Proc Natl Acad Sci U S A (1977) 7.92
A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev (1998) 7.72
Genetics of poliovirus. Annu Rev Genet (1993) 7.41
The 5' end of poliovirus mRNA is not capped with m7G(5')ppp(5')Np. Proc Natl Acad Sci U S A (1976) 7.26
Initiation of protein synthesis by internal entry of ribosomes into the 5' nontranslated region of encephalomyocarditis virus RNA in vivo. J Virol (1989) 7.01
Viral proteinases. Annu Rev Biochem (1988) 6.76
Cap-independent translation of encephalomyocarditis virus RNA: structural elements of the internal ribosomal entry site and involvement of a cellular 57-kD RNA-binding protein. Genes Dev (1990) 6.64
Canonical eukaryotic initiation factors determine initiation of translation by internal ribosomal entry. Mol Cell Biol (1996) 6.35
The separation of soluble ribonucleic acids on benzoylated diethylaminoethylcellulose. Biochemistry (1967) 6.04
Molecular mechanisms of translation initiation in eukaryotes. Proc Natl Acad Sci U S A (2001) 5.80
The location of the polio genome protein in viral RNAs and its implication for RNA synthesis. Nature (1977) 5.61
A second virus-encoded proteinase involved in proteolytic processing of poliovirus polyprotein. Cell (1986) 5.53
Proteolytic processing of poliovirus polypeptides: antibodies to polypeptide P3-7c inhibit cleavage at glutamine-glycine pairs. Proc Natl Acad Sci U S A (1982) 5.50
Eukaryotic ribosomes require initiation factors 1 and 1A to locate initiation codons. Nature (1998) 5.43
Polyadenylic acid at the 3'-terminus of poliovirus RNA. Proc Natl Acad Sci U S A (1972) 5.42
Systematic nomenclature of picornavirus proteins. J Virol (1984) 5.26
Cell-free, de novo synthesis of poliovirus. Science (1991) 5.09
A cytoplasmic 57-kDa protein that is required for translation of picornavirus RNA by internal ribosomal entry is identical to the nuclear pyrimidine tract-binding protein. Proc Natl Acad Sci U S A (1993) 4.71
O4-(5'-uridylyl)tyrosine is the bond between the genome-linked protein and the RNA of poliovirus. Proc Natl Acad Sci U S A (1978) 4.68
Initiation of protein synthesis from the A site of the ribosome. Cell (2000) 4.56
In vitro translation of poliovirus RNA: utilization of internal initiation sites in reticulocyte lysate. J Virol (1984) 4.54
Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J Virol (1987) 4.52
Functional dissection of eukaryotic initiation factor 4F: the 4A subunit and the central domain of the 4G subunit are sufficient to mediate internal entry of 43S preinitiation complexes. Mol Cell Biol (1996) 4.42
Production of infectious poliovirus from cloned cDNA is dramatically increased by SV40 transcription and replication signals. Nucleic Acids Res (1984) 4.19
The joining of ribosomal subunits in eukaryotes requires eIF5B. Nature (2000) 4.01
The 5'-terminal structures of poliovirion RNA and poliovirus mRNA differ only in the genome-linked protein VPg. Proc Natl Acad Sci U S A (1977) 3.97
Genetic analysis of the attenuation phenotype of poliovirus type 1. J Virol (1986) 3.94
Defective interfering particles of poliovirus. I. Isolation and physical properties. J Virol (1971) 3.74
Protein-primed RNA synthesis by purified poliovirus RNA polymerase. Nature (1998) 3.64
Identification of the initiation site of poliovirus polyprotein synthesis. J Virol (1982) 3.62
Membrane-dependent uridylylation of the genome-linked protein VPg of poliovirus. Proc Natl Acad Sci U S A (1983) 3.58
Interaction of poliovirus polypeptide 3CDpro with the 5' and 3' termini of the poliovirus genome. Identification of viral and cellular cofactors needed for efficient binding. J Biol Chem (1994) 3.45
Priming for and induction of anti-poliovirus neutralizing antibodies by synthetic peptides. Nature (1983) 3.35
Specific interaction of eukaryotic translation initiation factor 3 with the 5' nontranslated regions of hepatitis C virus and classical swine fever virus RNAs. J Virol (1998) 3.33
Membrane fractions active in poliovirus RNA replication contain VPg precursor polypeptides. Virology (1983) 3.28
Initiation of poliovirus plus-strand RNA synthesis in a membrane complex of infected HeLa cells. J Virol (1986) 3.24
Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C. J Virol (1986) 3.15
Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. J Virol (2000) 3.14
A membrane-associated precursor to poliovirus VPg identified by immunoprecipitation with antibodies directed against a synthetic heptapeptide. Cell (1982) 3.07
Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I. Science (1988) 3.03
Genome-linked proteins of viruses. Cell (1982) 3.02
Similarity in gene organization and homology between proteins of animal picornaviruses and a plant comovirus suggest common ancestry of these virus families. Nucleic Acids Res (1984) 2.99
Implications of the picornavirus capsid structure for polyprotein processing. Proc Natl Acad Sci U S A (1987) 2.99
Poliovirus polypeptide precursors: expression in vitro and processing by exogenous 3C and 2A proteinases. Proc Natl Acad Sci U S A (1987) 2.98
Poliovirus replication proteins: RNA sequence encoding P3-1b and the sites of proteolytic processing. Proc Natl Acad Sci U S A (1981) 2.91
Translation of poliovirus RNA: role of an essential cis-acting oligopyrimidine element within the 5' nontranslated region and involvement of a cellular 57-kilodalton protein. J Virol (1991) 2.86
A cell cycle-dependent protein serves as a template-specific translation initiation factor. Genes Dev (2000) 2.84
Poliovirus chimeras replicating under the translational control of genetic elements of hepatitis C virus reveal unusual properties of the internal ribosomal entry site of hepatitis C virus. Proc Natl Acad Sci U S A (1996) 2.78
Internal ribosomal entry site substitution eliminates neurovirulence in intergeneric poliovirus recombinants. Proc Natl Acad Sci U S A (1996) 2.71
Poliovirus neutralization epitopes: analysis and localization with neutralizing monoclonal antibodies. J Virol (1982) 2.63
Physical association of eukaryotic initiation factor 4G (eIF4G) with eIF4A strongly enhances binding of eIF4G to the internal ribosomal entry site of encephalomyocarditis virus and is required for internal initiation of translation. Mol Cell Biol (2000) 2.58
Sequence studies of poliovirus RNA. I. Characterization of the 5'-terminus. J Mol Biol (1972) 2.56
Cap-independent translation of picornavirus RNAs: structure and function of the internal ribosomal entry site. Enzyme (1990) 2.51
Interaction between the 5'-terminal cloverleaf and 3AB/3CDpro of poliovirus is essential for RNA replication. J Virol (1995) 2.47
A conserved HEAT domain within eIF4G directs assembly of the translation initiation machinery. Mol Cell (2001) 2.43
Interaction of the poliovirus receptor with poliovirus. Proc Natl Acad Sci U S A (2000) 2.42
Replication of picornaviruses. I. Evidence from in vitro RNA synthesis that poly(A) of the poliovirus genome is genetically coded. J Virol (1975) 2.42
Stable hairpin structure within the 5'-terminal 85 nucleotides of poliovirus RNA. J Virol (1981) 2.40
Protein processing map of poliovirus. J Virol (1984) 2.33
Production of guanidine-resistant and -dependent poliovirus mutants from cloned cDNA: mutations in polypeptide 2C are directly responsible for altered guanidine sensitivity. J Virol (1986) 2.33
The cellular polypeptide p57 (pyrimidine tract-binding protein) binds to multiple sites in the poliovirus 5' nontranslated region. J Virol (1994) 2.29
Expression of a cloned gene segment of poliovirus in E. coli: evidence for autocatalytic production of the viral proteinase. Cell (1984) 2.29
In vitro phenotypic markers of a poliovirus recombinant constructed from infectious cDNA clones of the neurovirulent Mahoney strain and the attenuated Sabin 1 strain. J Virol (1985) 2.26
Functional basis of poliovirus neutralization determined with monospecific neutralizing antibodies. J Virol (1983) 2.24
The eIF1A solution structure reveals a large RNA-binding surface important for scanning function. Mol Cell (2000) 2.24
Structure and interactions of the translation initiation factor eIF1. EMBO J (1999) 2.24
Translation eukaryotic initiation factor 4G recognizes a specific structural element within the internal ribosome entry site of encephalomyocarditis virus RNA. J Biol Chem (1998) 2.22
An enzymatic footprinting analysis of the interaction of 40S ribosomal subunits with the internal ribosomal entry site of hepatitis C virus. J Virol (2000) 2.21
"Fingerprinting" high molecular weight RNA by two-dimensional gel electrophoresis: application to poliovirus RNA. Nucleic Acids Res (1976) 2.20
Genetic and biochemical studies of poliovirus cis-acting replication element cre in relation to VPg uridylylation. J Virol (2000) 2.18
Bivalent attachment of antibody onto poliovirus leads to conformational alteration and neutralization. J Virol (1983) 2.18
Polioviruses containing picornavirus type 1 and/or type 2 internal ribosomal entry site elements: genetic hybrids and the expression of a foreign gene. Proc Natl Acad Sci U S A (1994) 2.17
Analysis of RNA synthesis of type 1 poliovirus by using an in vitro molecular genetic approach. J Virol (1987) 2.14
Capsid protein VP4 of poliovirus is N-myristoylated. Proc Natl Acad Sci U S A (1987) 2.12
Carboxy-terminal analysis of poliovirus proteins: termination of poliovirus RNA translation and location of unique poliovirus polyprotein cleavage sites. J Virol (1982) 2.11
Cardioviral internal ribosomal entry site is functional in a genetically engineered dicistronic poliovirus. Nature (1992) 2.10
Processing of in vitro-synthesized gag precursor proteins of human immunodeficiency virus (HIV) type 1 by HIV proteinase generated in Escherichia coli. J Virol (1988) 2.09
Poliovirus proteinase 3C: large-scale expression, purification, and specific cleavage activity on natural and synthetic substrates in vitro. J Virol (1988) 2.09
Intergeneric poliovirus recombinants for the treatment of malignant glioma. Proc Natl Acad Sci U S A (2000) 2.08
Properties of purified recombinant poliovirus protein 3aB as substrate for viral proteinases and as co-factor for RNA polymerase 3Dpol. J Biol Chem (1994) 2.07
Poliovirus type 1/type 3 antigenic hybrid virus constructed in vitro elicits type 1 and type 3 neutralizing antibodies in rabbits and monkeys. Proc Natl Acad Sci U S A (1988) 2.07
Cleavage sites in the polypeptide precursors of poliovirus protein P2-X. Virology (1981) 2.04
Sequence studies of poliovirus RNA. III. Polyuridylic acid and polyadenylic acid as components of the purified poliovirus replicative intermediate. J Mol Biol (1975) 2.04
Proteolytic processing of polyproteins in the replication of RNA viruses. Biochemistry (1989) 2.04
Cleavage of the cap binding protein complex polypeptide p220 is not effected by the second poliovirus protease 2A. Virology (1986) 2.02
The genome of poliovirus is an exceptional eukaryotic mRNA. Prog Nucleic Acid Res Mol Biol (1976) 1.99
Cleavage sites within the poliovirus capsid protein precursors. J Virol (1982) 1.95
Poly (A) and poly (U) in poliovirus double stranded RNA. Nat New Biol (1973) 1.95
A simple method for isolating highly purified yeast phenylalanine transfer ribonucleic acid. Biochemistry (1968) 1.93
Characterization of the nucleoside triphosphatase activity of poliovirus protein 2C reveals a mechanism by which guanidine inhibits poliovirus replication. J Biol Chem (1999) 1.91
Purification and characterization of poliovirus polypeptide 3CD, a proteinase and a precursor for RNA polymerase. J Virol (1992) 1.90
The genome-linked protein of picornaviruses. IV. Difference in the VPg's of encephalomyocarditis virus and poliovirus as evidence that the genome-linked proteins are virus-coded. Virology (1978) 1.89